PAHC vs ZBH: fair value comparison
Phibro Animal Health Corporation and Zimmer Biomet Holdings, Inc. · Updated 2026-09-06
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, ZBH currently sits closer to the top of our discount ranking. ZBH carries the stronger quality grade. PAHC carries the stronger momentum grade.
| PAHC | ZBH | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $37.15 | $98.07 |
| 12-month range | $29.76–$54.68 | $82.90–$100.56 |
| Sector rank | #42 of 113 Healthcare | #39 of 113 Healthcare |
| Quality grade | D | B |
| Momentum grade | A | B |
| Leverage | High | Moderate |
| Margin trend | — | Stable |
| Revenue growth | — | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | — |
| DCF cross-check | — | Undervalued |
| 52-week position | The lower-middle quarter | The top quarter |
Full single-stock breakdowns: PAHC fair value analysis · ZBH fair value analysis